Patient safety, news and press releases from EMA
- Call for companies to register their Industry Single Point of Contact (i-SPOC) on supply and availability, , 28/06/2022
- Monkeypox: EMA starts review for Imvanex, CHMP, 28/06/2022
- Hydroxyethyl-starch solutions for infusion recommended for suspension from the market, CMDh, 25/02/2022
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 June 2022, CHMP, 24/06/2022
- First gene therapy to treat severe haemophilia A, CHMP, 24/06/2022
- EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU, CHMP, 23/06/2022
- EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17, PDCO, 23/06/2022
- EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17, CHMP, 23/06/2022
- Global regulators work towards strengthening collaboration on observational research beyond COVID-19 pandemic, , 20/06/2022
- EMA Management Board: highlights of June 2022 meeting, MB, 17/06/2022
MedWatch Safety Alert RSS Feed
- Bryant Ranch Prepack Inc. Issues Voluntary Nationwide Recall of Morphine Sulfate 30 mg Extended Release and Morphine Sulfate 60 mg Extended-Release Due to Label-Mix Up
- Do Not Use Baby Neck Floats Due to the Risk of Death or Injury: FDA Safety Communication
- 2022 Safety Communications
- GE Healthcare Recalls CARESCAPE R860 Ventilator Due to Early Failure of Backup Batteries that May Cause Unexpected Ventilator Shut Down
- 2022 Medical Device Recalls
- Medtronic Recalls HeartWare HVAD System Batteries Due to Battery Failure
- Baxter Healthcare Corporation Recalls Volara System For Risk Of Respiratory Distress In Ventilated Patients During Home Use
- BD Announces Voluntary Recall on Intraosseous Products
- Vi-Jon, LLC Issues Voluntary Nationwide Recall of CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor Due to Microbial Contamination
- UPDATE on Type III Endoleaks Associated with Endovascular Graft Systems – Letter to Health Care Providers